Mitochondrial abnormalities-A link to idiosyncratic drug hepatotoxicity?

10.1016/j.taap.2006.12.013Toxicology and Applied Pharmacology220192-10

Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities

10.1093/toxsci/kfl180Toxicological Sciences971205-21

Troglitazone-induced hepatic mitochondrial proteome expression dynamics in heterozygous Sod2+/-mice: Two-stage oxidative injury

Toxicology and Applied Pharmacology231143-51TXAP

Critical role of free cytosolic calcium, but not uncoupling, in mitochondrial permeability transition and cell death induced by diclofenac oxidative metabolites in immortalized human hepatocytes

10.1016/j.taap.2006.09.012Toxicology and Applied Pharmacology2173322-33

The mitochondrial superoxide/thioredoxin-2/ask1 signaling pathway is critically involved in troglitazone-induced cell injury to human hepatocytes

10.1093/toxsci/kfm273Toxicological Sciences1012341-349TOSC

Oxidative bioactivation and toxicity of leflunomide in immortalized human hepatocytes and kinetics of the non-enzymatic conversion to its major metabolite, A77 1726

10.2174/187231208785425791Drug Metabolism Letters23153-15

Nimesulide-induced hepatic mitochondrial injury in heterozygous Sod2+/-mice

10.1016/j.freeradbiomed.2005.08.038Free Radical Biology and Medicine403420-42

Drug acyl glucuronides: Reactivity and analytical implication

Current Pharmaceutical Analysis23259-27